Description

GLP-1TZ is a dual-pathway analog modeled after some of the most widely studied compounds in modern metabolic science. By targeting both GLP-1 and GIP receptors, this research tool offers a robust platform for exploring insulin signaling, hunger regulation, and body composition in controlled environments.

Emerging literature suggests that dual agonists may outperform single-pathway models in areas like weight reduction and metabolic resilience. GLP-1TZ is designed to help researchers study the mechanisms behind those outcomes — with precision, potency, and high consistency.

⚠️ For research use only. Not intended for human or animal use. All claims reference published scientific literature.